A First Time in Man study to asses the safety and tolerability of AZD7624 in Healthy Subjects

Study identifier:D2550C00001

ClinicalTrials.gov identifier:NCT01754844

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Double-blind Placebo-controlled, Randomised, Single centre, First Time in Man Study to evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Inhaled Doses of AZD7624 in Healthy Subjects

Medical condition

Chronic obstructive pulmonary disease (COPD)

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD7624, Placebo to match

Sex

All

Actual Enrollment

57

Study type

Interventional

Age

18 Years - 55 Years

Date

Study Start Date: 01 Jan 2013
Primary Completion Date: 01 Aug 2013
Study Completion Date: 01 Aug 2013

Study design

Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Basic Science

Verification:

Verified 01 Nov 2016 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria